⌘K

Home/Filings/4/0001127602-11-010722

4//SEC Filing

Grant Stuart 4

Accession 0001127602-11-010722

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:49 PM ET

Size

16.4 KB

Accession

0001127602-11-010722

Insider Transaction Report

Form 4

Period: 2011-03-16

BIOCRYST PHARMACEUTICALS INCBCRX

SR VP & CFO

Transactions

Exercise/Conversion
Emp. Stock Option (Right to Buy)
2011-03-16−31,385→ 55,751 total
Exercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (31,385 underlying)
Sale
Common Stock
2011-03-16$3.39/sh−16,615$56,325→ 14,717 total
Exercise/Conversion
Emp. Stock Option (Right to Buy)
2011-03-16−17,000→ 38,751 total
Exercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (17,000 underlying)
Exercise/Conversion
Common Stock
2011-03-16$1.20/sh+16,615$19,938→ 31,332 total
Sale
Common Stock
2011-03-16$3.40/sh−6,000$20,400→ 57,102 total
Exercise/Conversion
Common Stock
2011-03-16$1.20/sh+17,000$20,400→ 63,102 total
Exercise/Conversion
Emp. Stock Option (Right to Buy)
2011-03-16−16,615→ 87,136 total
Exercise: $1.20From: 2010-03-02Exp: 2019-03-02→ Common Stock (16,615 underlying)
Exercise/Conversion
Common Stock
2011-03-16$1.20/sh+31,385$37,662→ 46,102 total

Footnotes (1)

[F1]These shares were transferred to the Company by the reporting person in partial payment of the exercise price of the stock options exercised on March 16, 2011.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001410397

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 4:49 PM ET
Size: 16.4 KB

View on SEC.gov